A Study to Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People
Clinical trial NCT05621239 · COMPLETED
Trial details
- NCT number
- NCT05621239
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-15
- Primary completion
- 2023-04-03
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.